Feature | Published:

Public biotechnology 2001—the numbers

Nature Biotechnology volume 20, pages 551555 (2002) | Download Citation

Subjects

Nature Biotechnology's annual survey of public biotechnology companies reveals that it was “business as usual” for the biotechnology sector, despite the year's economic downturn.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Author information

Affiliations

  1. Riku Lähteenmäki is a freelance writer working in Turku, Finland.

    • Riku Lähteenmäki
    •  & Liz Fletcher

Authors

  1. Search for Riku Lähteenmäki in:

  2. Search for Liz Fletcher in:

About this article

Publication history

Published

DOI

https://doi.org/10.1038/nbt0602-551

Further reading

Newsletter Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing